Clinical Trials

225 enrolled

Breast Neoplasms

NCT06926868 2026-03-11

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

500 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06062810 2026-03-09

Drugs-SNPs

600 enrolled

Breast Neoplasms

NCT03077841 2026-03-05

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer

Phase 2/3 Suspended

928 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT06009627 2026-02-10

Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients

119 enrolled

Breast Neoplasms

NCT07373782 2026-01-28

Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast Cancer

53 enrolled

Microcephaly, Primary Autosomal Recessive, 6, Breast Neoplasms

NCT07366840 2026-01-26

BRIGHT

268 enrolled

Breast Neoplasms

NCT05860465 2026-01-14

Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer

254 enrolled

Breast Neoplasms

NCT04290793 2026-01-07

Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer

113 enrolled

Breast Neoplasms

NCT07310758 2025-12-30

Contrast-enhanced Ultrasound for Sentinel Node Detection

BreastDermatologicHead & Neck

91 enrolled

Breast Neoplasms, Head and Neck Neoplasms, Melanoma

NCT07294508 2025-12-29

A Study to Evaluate HLX22 in Combination With HLX87 in Patients With HER2-Positive Recurrent or Metastatic Breast Cancer

706 enrolled

Breast Neoplasms

NCT07294534 2025-12-19

A Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX87in Combination With HLX22 or Pertuzumab in the Neoadjuvant Therapy of HER2-Positive Bresat Cancer

817 enrolled

Breast Neoplasms

NCT04862585 2025-08-20

Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel

130 enrolled 8 charts

Breast Carcinoma In Situ, Breast Neoplasms

NCT05744687 2025-08-17

Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer

374 enrolled

Breast Neoplasms

NCT05288777 2025-04-18

Breast53

45 enrolled

Breast Neoplasms

NCT01779206 2025-04-08

ADAPT

4,936 enrolled

Breast Neoplasms

NCT06769919 2025-01-10

A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for Early-stage Breast Cancer

340 enrolled

Breast Neoplasms

NCT05747794 2024-12-17

AIPAC-003

849 enrolled

Breast Neoplasms

NCT02883361 2024-12-05

MI for AIs

Phase 2/3 Withdrawn

Breast Neoplasms, Medication Adherence

NCT05889390 2024-12-03

NeoHTerMa

71 enrolled

Hyperthermia, Breast Neoplasms

NCT00221221 2024-11-05

Physical Activity Promotion in Breast Cancer Survivors

300 enrolled

Breast Neoplasms, Motor Activity

NCT03315364 2024-07-25

OPTIMAL

549 enrolled

Breast Neoplasms, Recurrence

NCT03500380 2024-02-20

A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases

301 enrolled

Breast Diseases, Breast Neoplasms

NCT06268327 2024-02-20

Adding Adjuvant Cisplatin and Gemicitabine Versus Capecitabine in Triple-negative Breast Cancer Patients in Non pCR After Neoadjuvant Standard Chemotherapy

30 enrolled

Breast Neoplasms

NCT02641847 2024-01-25

TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature

503 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05189535 2024-01-23

"Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients"

66 enrolled

Breast Neoplasms, Peripheral Nervous System Diseases

NCT05523609 2023-12-01

Vitamin D and Calcium Supplementation in Breast Cancer

40 enrolled

Breast Neoplasms

NCT02068092 2023-10-10

Olive Oil for High Risk Breast Cancer Prevention in Women

51 enrolled 6 charts

Breast Neoplasms

NCT03564171 2023-04-12

Prehabilitation for Women Undergoing Pre-operative Chemotherapy for Breast Cancer

63 enrolled

Breast Neoplasms

NCT05804916 2023-04-07

Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer

556 enrolled

Breast Neoplasms

NCT03354611 2023-03-16

Contrast-Enhanced Cone Beam Breast CT for Diagnostic Breast Imaging

Phase 2/3 Terminated

21 enrolled

Breast Neoplasms

NCT04803539 2023-02-21

Artemis

260 enrolled

Breast Neoplasms

NCT03150576 2022-11-14

PARTNER

780 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05103644 2022-11-02

Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"

60 enrolled

Breast Neoplasms

NCT01057069 2022-10-12

neo-TN

310 enrolled

Breast Neoplasms

NCT05518292 2022-09-28

Comparison of Analgesic Efficacy of Ultrasound Guided Rhomboid Intercostal Block Versus Serratus Anterior Plane Block for Mastectomy Surgery

60 enrolled

Breast Neoplasms

NCT00247975 2022-08-16

Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy

Phase 2/3 Terminated

36 enrolled

Breast Neoplasms, Heart Failure

NCT04429893 2022-08-02

Magnesium Sulphate to Bupivicaine in Serratus Anterior Plane Block in Modified Radical Mastectomy

80 enrolled

Breast Neoplasms

NCT05253066 2022-02-23

Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer

130 enrolled

Breast Neoplasms

NCT04059809 2021-08-13

Photobiomodulation for Breast Cancer Radiodermatitis

48 enrolled

Breast Neoplasms, Radiation Injuries, Radiodermatitis

NCT00397761 2021-02-17

Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer

Phase 2/3 Withdrawn

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT01150513 2021-02-09

Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-negative Breast Cancer

320 enrolled

Breast Neoplasms

NCT04736186 2021-02-03

Prevention and Treatment of Pyrrolitinib-associated Diarrhea

470 enrolled

Breast Neoplasms, Diarrhea

NCT00448266 2021-01-22

Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD

Phase 2/3 Terminated

12 enrolled

Breast Neoplasms

NCT04705909 2021-01-12

Efficacy of Statin Addition to Neoadjuvant Chemotherapy Protocols for Breast Cancer

60 enrolled

Breast Neoplasms

NCT03165149 2020-11-03

Effect of a Topical Ketamine on Acute and Chronic Pain, Dose Finding

90 enrolled

Breast Neoplasms

NCT02568839 2020-08-13

PREDIX HER2

202 enrolled

Breast Neoplasms

NCT00123669 2020-07-22

Primary Progesterone Therapy for Operable Breast Cancer

1,000 enrolled

Breast Neoplasms, Neoplasms

NCT04387630 2020-06-11

Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer.

120 enrolled